MITOXANTRONE HYDROCHLORIDE

MITOXANTRONE HYDROCHLORIDE was reported 6289 times

MITOXANTRONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELOBLAST PERCENTAGE DECREASED 7 0.5833
1 HAEMORRHAGIC ADRENAL INFARCTION 6 0.3750
2 HYPERTENSIVE HYDROCEPHALUS 8 0.3478
3 GRANULICATELLA INFECTION 10 0.2381
4 AMELOBLASTOMA 12 0.2264
5 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 23 0.1106
6 GENOTOXICITY 4 0.1053
7 ASPIRATION BONE MARROW ABNORMAL 14 0.1037
8 STOMATOCOCCAL INFECTION 12 0.0968
9 LEPTOTRICHIA INFECTION 4 0.0889
10 RETINOIC ACID SYNDROME 15 0.0872
11 ACUTE PROMYELOCYTIC LEUKAEMIA 88 0.0856
12 HEPATOSPLENIC CANDIDIASIS 12 0.0816
13 LINEAGE SWITCH LEUKAEMIA 4 0.0755
14 ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY 4 0.0741
15 PARASPINAL ABSCESS 11 0.0710
16 GALLBLADDER ADENOCARCINOMA 5 0.0704
17 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 7 0.0686
18 PERINEAL CELLULITIS 4 0.0678
19 MANTLE CELL LYMPHOMA STAGE IV 4 0.0667
20 HAEMORRHAGIC PNEUMONIA 4 0.0645
21 ABSCESS FUNGAL 11 0.0629
22 FOLLICULAR LYMPHOMA RECURRENT 5 0.0625
23 SEPTAL PANNICULITIS 5 0.0625
24 CHROMOSOMAL MUTATION 4 0.0588
25 ACUTE MYELOID LEUKAEMIA REFRACTORY 10 0.0581
26 LEUKAEMIC INFILTRATION 8 0.0571
27 ANTITHROMBIN III DEFICIENCY 5 0.0562
28 CLOSTRIDIUM BACTERAEMIA 12 0.0561
29 ACUTE MONOCYTIC LEUKAEMIA 10 0.0549
30 NON-HODGKIN'S LYMPHOMA RECURRENT 5 0.0543
31 T-CELL PROLYMPHOCYTIC LEUKAEMIA 5 0.0538
32 HIGH-GRADE B-CELL LYMPHOMA 10 0.0535
33 ABDOMINAL WALL WOUND 8 0.0519
34 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 10 0.0478
35 MINIMAL RESIDUAL DISEASE 22 0.0455
36 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 14 0.0447
37 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 6 0.0444
38 CHROMOSOMAL DELETION 7 0.0440
39 ACUTE MYELOMONOCYTIC LEUKAEMIA 11 0.0437
40 DYSTROPHIC CALCIFICATION 5 0.0435
41 CHLOROMA 18 0.0427
42 HAEMATOPOIETIC NEOPLASM 8 0.0426
43 LOWER RESPIRATORY TRACT INFECTION FUNGAL 16 0.0411
44 BACILLUS TEST POSITIVE 4 0.0404
45 LEUKAEMIA RECURRENT 68 0.0402
46 TREATMENT RELATED SECONDARY MALIGNANCY 8 0.0394
47 CLONAL EVOLUTION 4 0.0385
48 RESTRICTIVE CARDIOMYOPATHY 11 0.0363
49 LYMPHOMA TRANSFORMATION 13 0.0361
50 CEREBRAL FUNGAL INFECTION 10 0.0353
51 IDIOPATHIC PNEUMONIA SYNDROME 10 0.0336
52 LEUKAEMIA CUTIS 5 0.0325
53 GASTROENTERITIS ADENOVIRUS 5 0.0318
54 GASTROENTERITIS STAPHYLOCOCCAL 5 0.0318
55 HAEMOFILTRATION 6 0.0316
56 CHOLANGITIS INFECTIVE 8 0.0301
57 ACUTE MYELOID LEUKAEMIA RECURRENT 64 0.0298
58 LARGE GRANULAR LYMPHOCYTOSIS 10 0.0298
59 T-CELL TYPE ACUTE LEUKAEMIA 6 0.0294
60 CHROMOSOME ABNORMALITY 4 0.0290
61 ADENOVIRAL HAEMORRHAGIC CYSTITIS 6 0.0288
62 DISSEMINATED MUCORMYCOSIS 11 0.0279
63 CHROMOSOME ANALYSIS ABNORMAL 7 0.0276
64 RESPIRATORY TRACT INFECTION FUNGAL 14 0.0265
65 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 6 0.0259
66 KLEBSIELLA SEPSIS 29 0.0257
67 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 66 0.0256
68 PRIMARY HYPOGONADISM 4 0.0255
69 5Q MINUS SYNDROME 4 0.0250
70 FUNGAEMIA 39 0.0248
71 NEUROMYELITIS OPTICA 8 0.0240
72 HAEMOGLOBINAEMIA 4 0.0234
73 PERIPARTUM CARDIOMYOPATHY 4 0.0233
74 PIERRE ROBIN SYNDROME 5 0.0233
75 B PRECURSOR TYPE ACUTE LEUKAEMIA 9 0.0232
76 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 21 0.0227
77 NEUTROPENIC COLITIS 43 0.0208
78 CHRONIC HEPATITIS 16 0.0198
79 BLOOD BETA-D-GLUCAN INCREASED 6 0.0195
80 ACUTE MYELOID LEUKAEMIA 300 0.0192
81 GEOTRICHUM INFECTION 4 0.0190
82 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 13 0.0187
83 CEREBRAL ASPERGILLOSIS 11 0.0179
84 STENOTROPHOMONAS INFECTION 24 0.0177
85 MUCORMYCOSIS 46 0.0177
86 RHINOCEREBRAL MUCORMYCOSIS 6 0.0173
87 ENTEROCOCCAL SEPSIS 14 0.0173
88 FUSARIUM INFECTION 12 0.0171
89 MYELODYSPLASTIC SYNDROME 237 0.0164
90 STREPTOCOCCAL SEPSIS 19 0.0160
91 CYTOGENETIC ABNORMALITY 18 0.0159
92 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 15 0.0158
93 FUNGAL SEPSIS 13 0.0156
94 CNS VENTRICULITIS 5 0.0153
95 VENOOCCLUSIVE LIVER DISEASE 75 0.0152
96 CYTOTOXIC OEDEMA 4 0.0151
97 RELAPSING-REMITTING MULTIPLE SCLEROSIS 13 0.0150
98 SINUSITIS FUNGAL 12 0.0150
99 PSEUDOMONAL SEPSIS 26 0.0148
100 BACTERIAL SEPSIS 47 0.0144
101 STREPTOCOCCAL BACTERAEMIA 15 0.0138
102 CHRONIC MYELOMONOCYTIC LEUKAEMIA 9 0.0136
103 FEBRILE BONE MARROW APLASIA 58 0.0136
104 DYSBIOSIS 11 0.0134
105 MARROW HYPERPLASIA 9 0.0132
106 APOPTOSIS 4 0.0129
107 BONE MARROW INFILTRATION 5 0.0129
108 DEVICE RELATED BACTERAEMIA 4 0.0129
109 B-CELL LYMPHOMA RECURRENT 7 0.0129
110 DISSEMINATED ASPERGILLOSIS 6 0.0127
111 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 28 0.0127
112 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 27 0.0127
113 PARAKERATOSIS 4 0.0123
114 DIFFERENTIATION SYNDROME 9 0.0123
115 APLASIA 24 0.0122
116 FEBRILE NEUTROPENIA 770 0.0116
117 MANTLE CELL LYMPHOMA RECURRENT 5 0.0115
118 PNEUMATOSIS 5 0.0112
119 CENTRAL LINE INFECTION 4 0.0108
120 ACUTE LYMPHOCYTIC LEUKAEMIA 30 0.0106
121 SECOND PRIMARY MALIGNANCY 88 0.0106
122 HAEMATOTOXICITY 100 0.0105
123 BRONCHOPULMONARY ASPERGILLOSIS 81 0.0104
124 STEM CELL TRANSPLANT 26 0.0104
125 BLOOD CULTURE POSITIVE 31 0.0103
126 CONTINUOUS HAEMODIAFILTRATION 10 0.0102
127 CENTRAL NERVOUS SYSTEM LEUKAEMIA 4 0.0102
128 CANDIDA SEPSIS 9 0.0100
129 GRAFT VERSUS HOST DISEASE IN SKIN 22 0.0100
130 HEART TRANSPLANT 9 0.0099
131 ESCHERICHIA BACTERAEMIA 23 0.0098
132 HYPERAMMONAEMIC ENCEPHALOPATHY 17 0.0098
133 PSEUDOMONAS TEST POSITIVE 8 0.0098
134 PROSTATE CANCER RECURRENT 6 0.0097
135 DELUSIONAL DISORDER, PERSECUTORY TYPE 4 0.0095
136 PNEUMONIA FUNGAL 37 0.0094
137 STEATOHEPATITIS 5 0.0093
138 ACUTE LEUKAEMIA 15 0.0093
139 ENTEROCOCCUS TEST POSITIVE 6 0.0093
140 PNEUMONIA KLEBSIELLA 17 0.0092
141 CYTOMEGALOVIRUS CHORIORETINITIS 18 0.0092
142 ASPERGILLOSIS 12 0.0092
143 FOLLICULAR LYMPHOMA 8 0.0091
144 PULMONARY MYCOSIS 7 0.0090
145 CAECITIS 4 0.0089
146 CYSTITIS HAEMORRHAGIC 35 0.0087
147 STRONGYLOIDIASIS 14 0.0087
148 VENOOCCLUSIVE DISEASE 21 0.0084
149 GRAFT VERSUS HOST DISEASE IN LUNG 4 0.0084
150 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 32 0.0084
151 HEMIANOPIA HOMONYMOUS 6 0.0082
152 HISTIOCYTOSIS HAEMATOPHAGIC 24 0.0081
153 ENTEROCOCCAL INFECTION 39 0.0081
154 METASTASES TO BONE MARROW 4 0.0080
155 MYELOID LEUKAEMIA 4 0.0080
156 ASPERGILLUS INFECTION 52 0.0079
157 PNEUMONIA NECROTISING 5 0.0077
158 SYSTEMIC MYCOSIS 9 0.0077
159 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 5 0.0076
160 PULMONARY MUCORMYCOSIS 4 0.0076
161 MYELOPROLIFERATIVE NEOPLASM 5 0.0075
162 PNEUMOCYSTIS JIROVECII INFECTION 9 0.0075
163 OVARIAN FAILURE 4 0.0075
164 NEOPLASM RECURRENCE 25 0.0074
165 GRAFT VERSUS HOST DISEASE 53 0.0074
166 BONE MARROW FAILURE 149 0.0073
167 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 9 0.0073
168 ESCHERICHIA SEPSIS 21 0.0072
169 CRANIAL NERVE DISORDER 5 0.0072
170 KLEBSIELLA INFECTION 36 0.0071
171 HEPATITIS E 11 0.0070
172 CARDIOTOXICITY 62 0.0069
173 JC VIRUS INFECTION 11 0.0069
174 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0069
175 ENGRAFTMENT SYNDROME 4 0.0068
176 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 4 0.0068
177 CAPILLARY LEAK SYNDROME 14 0.0068
178 ALVEOLAR PROTEINOSIS 4 0.0068
179 APLASTIC ANAEMIA 35 0.0067
180 BLAST CELL COUNT INCREASED 7 0.0067
181 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 55 0.0067
182 GINGIVAL ULCERATION 5 0.0066
183 PRIMARY SEQUESTRUM 6 0.0066
184 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0064
185 MEGACOLON 10 0.0064
186 KLEBSIELLA BACTERAEMIA 6 0.0063
187 JUGULAR VEIN THROMBOSIS 11 0.0062
188 RETINAL DEGENERATION 8 0.0062
189 BONE MARROW DEPRESSION 6 0.0061
190 NON-HODGKIN'S LYMPHOMA 8 0.0061
191 BACTERAEMIA 72 0.0061
192 HYPERPHOSPHATAEMIA 13 0.0060
193 ILEAL PERFORATION 4 0.0060
194 CLOSTRIDIUM TEST POSITIVE 13 0.0059
195 MULTIPLE-DRUG RESISTANCE 18 0.0058
196 HYPOGAMMAGLOBULINAEMIA 38 0.0058
197 SECONDARY IMMUNODEFICIENCY 7 0.0058
198 STAPHYLOCOCCAL SEPSIS 28 0.0057
199 ENTEROCOCCAL BACTERAEMIA 6 0.0057
200 CHRONIC MYELOID LEUKAEMIA 26 0.0056
201 LYMPHOCYTOSIS 12 0.0056
202 GENE MUTATION 11 0.0056
203 PORTAL HYPERTENSION 17 0.0055
204 ESCHAR 4 0.0055
205 PSEUDOMONAS INFECTION 47 0.0055
206 SOFT TISSUE INFECTION 10 0.0055
207 ACUTE GRAFT VERSUS HOST DISEASE 25 0.0055
208 AMINO ACID LEVEL INCREASED 4 0.0054
209 SUBILEUS 11 0.0053
210 VITH NERVE PARALYSIS 6 0.0053
211 SYSTEMIC CANDIDA 13 0.0052
212 CYTOMEGALOVIRUS VIRAEMIA 23 0.0052
213 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 12 0.0052
214 ASEPTIC NECROSIS BONE 4 0.0051
215 BLOOD FIBRINOGEN INCREASED 4 0.0051
216 PNEUMONIA MYCOPLASMAL 4 0.0050
217 ESCHERICHIA TEST POSITIVE 6 0.0050
218 PERIPHERAL MOTOR NEUROPATHY 7 0.0050
219 PERIODONTAL DISEASE 7 0.0050
220 HERPES ZOSTER DISSEMINATED 4 0.0050
221 DILATED CARDIOMYOPATHY 5 0.0049
222 VENA CAVA THROMBOSIS 8 0.0048
223 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 6 0.0048
224 CONGESTIVE CARDIOMYOPATHY 20 0.0048
225 CYTOMEGALOVIRUS COLITIS 11 0.0048
226 BENIGN INTRACRANIAL HYPERTENSION 6 0.0048
227 HYPOPERFUSION 5 0.0048
228 ESCHERICHIA INFECTION 39 0.0047
229 MUCOSAL INFLAMMATION 124 0.0047
230 PSEUDOMONAL BACTERAEMIA 4 0.0047
231 PLATELET TRANSFUSION 6 0.0047
232 HEPATITIS B 28 0.0046
233 BONE NEOPLASM 5 0.0046
234 PNEUMONIA CYTOMEGALOVIRAL 9 0.0046
235 NEUTROPENIC SEPSIS 33 0.0046
236 SEPTIC SHOCK 198 0.0045
237 DIFFUSE LARGE B-CELL LYMPHOMA 35 0.0045
238 CYTOPENIA 54 0.0044
239 EXTENSOR PLANTAR RESPONSE 4 0.0043
240 PREMATURE MENOPAUSE 4 0.0043
241 RESPIRATORY ALKALOSIS 7 0.0043
242 PANCYTOPENIA 238 0.0043
243 BONE MARROW TOXICITY 5 0.0042
244 BONE MARROW TRANSPLANT 8 0.0042
245 PULMONARY HAEMORRHAGE 33 0.0042
246 HORMONE-REFRACTORY PROSTATE CANCER 5 0.0042
247 PNEUMONIA INFLUENZAL 5 0.0042
248 NEUTROPENIC INFECTION 4 0.0042
249 ACTINOMYCOSIS 4 0.0042
250 ENTEROBACTER INFECTION 7 0.0042
251 CHRONIC GRAFT VERSUS HOST DISEASE 15 0.0042
252 HYPERBILIRUBINAEMIA 43 0.0041
253 CARDIOMYOPATHY 61 0.0041
254 IDIOSYNCRATIC DRUG REACTION 4 0.0041
255 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 5 0.0040
256 GUILLAIN-BARRE SYNDROME 19 0.0039
257 MULTIPLE ORGAN DYSFUNCTION SYNDROME 111 0.0039
258 MYELOSUPPRESSION 141 0.0039
259 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
260 ALVEOLITIS ALLERGIC 4 0.0039
261 DILATATION VENTRICULAR 8 0.0038
262 OEDEMA MUCOSAL 4 0.0038
263 STAPHYLOCOCCUS TEST POSITIVE 8 0.0038
264 HEPATITIS B REACTIVATION 12 0.0038
265 LEFT VENTRICULAR FAILURE 13 0.0038
266 TUMOUR LYSIS SYNDROME 33 0.0037
267 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
268 NECROTISING FASCIITIS 13 0.0037
269 HAEMORRHAGIC DISORDER 4 0.0037
270 CEREBELLAR SYNDROME 8 0.0036
271 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 27 0.0036
272 BACTERIAL TEST POSITIVE 8 0.0036
273 ECHOCARDIOGRAM ABNORMAL 5 0.0036
274 VENOUS THROMBOSIS 14 0.0036
275 MALIGNANT PLEURAL EFFUSION 6 0.0036
276 ENTEROCOLITIS 20 0.0035
277 NEUTROPENIA 467 0.0034
278 DISSEMINATED INTRAVASCULAR COAGULATION 48 0.0034
279 BILE DUCT CANCER 4 0.0034
280 GASTROINTESTINAL TOXICITY 16 0.0033
281 SMALL CELL LUNG CANCER 5 0.0033
282 BONE MARROW DISORDER 10 0.0033
283 DRUG RESISTANCE 85 0.0033
284 MYELOFIBROSIS 10 0.0033
285 VARICES OESOPHAGEAL 10 0.0033
286 PROSTATE CANCER METASTATIC 11 0.0033
287 MANTLE CELL LYMPHOMA 5 0.0033
288 HYPERTRIGLYCERIDAEMIA 19 0.0032
289 OSTEOSCLEROSIS 5 0.0032
290 MYELOPATHY 6 0.0032
291 GASTROINTESTINAL ULCER 7 0.0032
292 PNEUMOCYSTIS JIROVECI PNEUMONIA 7 0.0031
293 LEFT ATRIAL DILATATION 4 0.0031
294 THROMBOCYTOPENIA 349 0.0031
295 CANDIDA INFECTION 52 0.0031
296 EJECTION FRACTION DECREASED 47 0.0030
297 HEPATIC LESION 13 0.0030
298 INTESTINAL DILATATION 4 0.0030
299 HYPERAMMONAEMIA 15 0.0030
300 LUNG ADENOCARCINOMA 9 0.0030
301 ENTERITIS INFECTIOUS 5 0.0029
302 SEPSIS 327 0.0029
303 PERIPHERAL SENSORY NEUROPATHY 17 0.0029
304 LYMPHOPENIA 41 0.0029
305 VITREOUS HAEMORRHAGE 8 0.0029
306 MYELITIS TRANSVERSE 4 0.0028
307 NEUTROPHIL COUNT ABNORMAL 8 0.0028
308 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 5 0.0028
309 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
310 MENINGITIS BACTERIAL 4 0.0028
311 HAIR DISORDER 23 0.0028
312 APPENDICITIS 26 0.0028
313 LYMPHOMA 43 0.0028
314 PLATELET DISORDER 7 0.0028
315 ADENOVIRUS INFECTION 8 0.0028
316 ENCEPHALOPATHY 67 0.0027
317 NORMOCYTIC ANAEMIA 4 0.0027
318 CYTOMEGALOVIRUS INFECTION REACTIVATION 12 0.0027
319 CYTOMEGALOVIRUS INFECTION 45 0.0027
320 OPPORTUNISTIC INFECTION 5 0.0027
321 POTENTIATING DRUG INTERACTION 9 0.0027
322 BRAIN HERNIATION 8 0.0027
323 FUNGAL INFECTION 89 0.0027
324 METASTASIS 19 0.0027
325 LEUKAEMIA 25 0.0026
326 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
327 AREFLEXIA 7 0.0026
328 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
329 NEUROLOGICAL DECOMPENSATION 6 0.0026
330 INVASIVE DUCTAL BREAST CARCINOMA 7 0.0026
331 PLEURITIC PAIN 7 0.0025
332 PNEUMONIA VIRAL 8 0.0025
333 LUNG CONSOLIDATION 7 0.0025
334 PNEUMONIA LEGIONELLA 4 0.0025
335 CYTOKINE RELEASE SYNDROME 50 0.0025
336 LUNG INFILTRATION 22 0.0025
337 MULTI-ORGAN FAILURE 43 0.0025
338 DISINHIBITION 4 0.0025
339 DEVICE RELATED SEPSIS 5 0.0025
340 LEUKOPENIA 123 0.0025
341 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
342 HEPATOTOXICITY 54 0.0024
343 CARDIAC DYSFUNCTION 9 0.0024
344 PULMONARY TOXICITY 17 0.0024
345 CEREBELLAR INFARCTION 4 0.0024
346 GASTROINTESTINAL INFECTION 21 0.0023
347 ENDOCARDITIS 12 0.0023
348 HEPATOSPLENOMEGALY 6 0.0023
349 AORTIC ARTERIOSCLEROSIS 6 0.0023
350 ACUTE RESPIRATORY DISTRESS SYNDROME 41 0.0023
351 BLOOD CREATININE ABNORMAL 8 0.0023
352 THERAPY PARTIAL RESPONDER 36 0.0023
353 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
354 RESPIRATORY FAILURE 168 0.0023
355 PARAPARESIS 4 0.0022
356 CHOLESTATIC LIVER INJURY 5 0.0022
357 PARESIS 5 0.0022
358 ILEUS PARALYTIC 10 0.0022
359 NEUROTOXICITY 39 0.0022
360 ABDOMINAL TENDERNESS 11 0.0022
361 HYPERNATRAEMIA 11 0.0022
362 SUBDURAL HAEMORRHAGE 6 0.0022
363 COLITIS 83 0.0022
364 PNEUMOPERITONEUM 4 0.0022
365 GRANULOCYTE COUNT DECREASED 4 0.0022
366 HERPES SIMPLEX 14 0.0022
367 LEUKOENCEPHALOPATHY 8 0.0021
368 URINARY TRACT OBSTRUCTION 5 0.0021
369 PULMONARY TUBERCULOSIS 9 0.0021
370 NEOPLASM PROGRESSION 73 0.0021
371 ACIDOSIS 16 0.0021
372 LYMPHADENITIS 5 0.0021
373 GASTROINTESTINAL NECROSIS 6 0.0021
374 METASTASES TO LIVER 36 0.0020
375 WOUND SECRETION 8 0.0020
376 HYDROCEPHALUS 11 0.0020
377 ERYTHEMA NODOSUM 7 0.0020
378 MADAROSIS 23 0.0020
379 RETINAL HAEMORRHAGE 14 0.0020
380 NEUTROPHIL COUNT DECREASED 80 0.0020
381 RECURRENT CANCER 8 0.0020
382 OSTEOLYSIS 4 0.0020
383 METASTASES TO BONE 32 0.0019
384 DIASTOLIC DYSFUNCTION 6 0.0019
385 AGRANULOCYTOSIS 36 0.0019
386 LUNG INFECTION 30 0.0019
387 HYPOALBUMINAEMIA 15 0.0019
388 HAIR COLOUR CHANGES 24 0.0019
389 VENTRICULAR DYSFUNCTION 5 0.0019
390 PARTIAL SEIZURES 10 0.0019
391 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
392 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
393 HEPATIC FAILURE 57 0.0019
394 HYPOVOLAEMIC SHOCK 9 0.0019
395 PURULENT DISCHARGE 8 0.0019
396 ACUTE RESPIRATORY FAILURE 36 0.0019
397 FACIAL PALSY 4 0.0019
398 DISEASE PROGRESSION 219 0.0018
399 TACHYPNOEA 25 0.0018
400 HEPATOMEGALY 18 0.0018
401 ENDOMETRIAL CANCER 4 0.0018
402 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
403 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0018
404 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
405 HAIR TEXTURE ABNORMAL 24 0.0018
406 BK VIRUS INFECTION 6 0.0018
407 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
408 TOXIC ENCEPHALOPATHY 9 0.0018
409 CLOSTRIDIAL INFECTION 6 0.0018
410 OLIGURIA 11 0.0018
411 SKIN TOXICITY 10 0.0018
412 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 9 0.0018
413 SUBARACHNOID HAEMORRHAGE 18 0.0018
414 B-CELL LYMPHOMA 6 0.0018
415 DISTRIBUTIVE SHOCK 4 0.0018
416 AMMONIA INCREASED 9 0.0018
417 DEVICE RELATED INFECTION 27 0.0018
418 BRONCHOPNEUMONIA 6 0.0018
419 ENCEPHALITIS 12 0.0017
420 STAPHYLOCOCCAL INFECTION 57 0.0017
421 OVARIAN HYPERSTIMULATION SYNDROME 4 0.0017
422 BILIRUBIN CONJUGATED INCREASED 4 0.0017
423 SPLENOMEGALY 20 0.0017
424 PURPURA 15 0.0017
425 PULSE ABSENT 8 0.0017
426 NON-SMALL CELL LUNG CANCER 8 0.0017
427 TUMOUR MARKER INCREASED 8 0.0017
428 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
429 PANNICULITIS 4 0.0017
430 CARDIAC FAILURE ACUTE 11 0.0016
431 PATHOGEN RESISTANCE 15 0.0016
432 PERICARDIAL EFFUSION 38 0.0016
433 TRICUSPID VALVE INCOMPETENCE 13 0.0016
434 PSYCHOLOGICAL TRAUMA 14 0.0016
435 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
436 OSTEONECROSIS 53 0.0016
437 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
438 URINE OUTPUT DECREASED 14 0.0016
439 BLOOD CREATININE DECREASED 5 0.0016
440 CEREBRAL HAEMORRHAGE 57 0.0016
441 HEPATIC FUNCTION ABNORMAL 59 0.0016
442 THERAPY NON-RESPONDER 71 0.0016
443 ABDOMINAL INFECTION 4 0.0016
444 EMBOLISM 13 0.0016
445 METASTASES TO LUNG 18 0.0016
446 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0016
447 OESOPHAGITIS 17 0.0016
448 THROMBOTIC MICROANGIOPATHY 15 0.0015
449 PETECHIAE 16 0.0015
450 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 5 0.0015
451 OESOPHAGEAL CANDIDIASIS 6 0.0015
452 ABSCESS 24 0.0015
453 METASTASES TO SPINE 5 0.0015
454 LARYNGOSPASM 4 0.0015
455 HYPOXIA 52 0.0015
456 HAEMORRHAGE INTRACRANIAL 22 0.0015
457 PANCREATITIS ACUTE 33 0.0015
458 CLUMSINESS 4 0.0015
459 DEMYELINATION 6 0.0015
460 ORAL FUNGAL INFECTION 4 0.0015
461 HYPERKERATOSIS 8 0.0014
462 VIITH NERVE PARALYSIS 5 0.0014
463 BACTERIAL INFECTION 27 0.0014
464 PLEURAL EFFUSION 88 0.0014
465 BLOOD BILIRUBIN INCREASED 39 0.0014
466 THROMBOPHLEBITIS 5 0.0014
467 INTESTINAL PERFORATION 16 0.0014
468 ACUTE PULMONARY OEDEMA 8 0.0014
469 BRAIN OEDEMA 18 0.0014
470 CARDIAC FAILURE 114 0.0014
471 RESPIRATORY DISTRESS 39 0.0014
472 LYMPHADENOPATHY 50 0.0014
473 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
474 GRANULOCYTOPENIA 8 0.0014
475 HAEMOGLOBIN ABNORMAL 9 0.0014
476 DERMATITIS EXFOLIATIVE 7 0.0014
477 INFECTION 202 0.0014
478 DRUG TOXICITY 19 0.0014
479 PARAPLEGIA 4 0.0014
480 BONE DISORDER 25 0.0014
481 LUMBAR SPINAL STENOSIS 4 0.0014
482 HYPOPHOSPHATAEMIA 10 0.0014
483 HEPATITIS FULMINANT 4 0.0013
484 MENINGITIS 9 0.0013
485 PROTEIN TOTAL DECREASED 5 0.0013
486 COAGULOPATHY 22 0.0013
487 IMMUNE THROMBOCYTOPENIA 6 0.0013
488 PNEUMONIA BACTERIAL 12 0.0013
489 COMPRESSION FRACTURE 7 0.0013
490 HEMIPARESIS 22 0.0013
491 PNEUMONITIS 35 0.0013
492 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
493 SINUS TACHYCARDIA 18 0.0013
494 IRIDOCYCLITIS 4 0.0013
495 ASCITES 37 0.0013
496 ENTERITIS 8 0.0012
497 CANDIDIASIS 5 0.0012
498 TRIGEMINAL NEURALGIA 5 0.0012
499 LOOSE TOOTH 4 0.0012
500 NEOPLASM 14 0.0012
501 RALES 7 0.0012
502 BLOOD UREA INCREASED 20 0.0012
503 METASTASES TO LYMPH NODES 8 0.0012
504 HEPATIC CYST 4 0.0012
505 PROTHROMBIN TIME PROLONGED 7 0.0012
506 TRANSAMINASES INCREASED 26 0.0012
507 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
508 SKIN HYPERPIGMENTATION 10 0.0012
509 NO THERAPEUTIC RESPONSE 14 0.0011
510 CARDIOMEGALY 14 0.0011
511 CHEILITIS 6 0.0011
512 HEPATIC CYTOLYSIS 14 0.0011
513 PLATELET COUNT DECREASED 116 0.0011
514 SHOCK 25 0.0011
515 HYPOKALAEMIA 50 0.0011
516 HEMIPLEGIA 9 0.0011
517 STREPTOCOCCAL INFECTION 6 0.0011
518 PYREXIA 373 0.0011
519 NECROSIS 6 0.0011
520 HAEMODIALYSIS 9 0.0011
521 SQUAMOUS CELL CARCINOMA 10 0.0011
522 WHITE BLOOD CELL COUNT DECREASED 115 0.0011
523 CHOLECYSTITIS ACUTE 6 0.0011
524 CATHETER SITE INFECTION 4 0.0011
525 STOMATITIS 64 0.0011
526 MALIGNANT NEOPLASM PROGRESSION 108 0.0011
527 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
528 OSTEONECROSIS OF JAW 26 0.0010
529 HAEMODYNAMIC INSTABILITY 8 0.0010
530 SKIN MASS 7 0.0010
531 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
532 CARDIOGENIC SHOCK 15 0.0010
533 TOOTH EXTRACTION 13 0.0010
534 SUBCUTANEOUS ABSCESS 5 0.0010
535 HERPES VIRUS INFECTION 6 0.0010
536 ANAEMIA 198 0.0010
537 APHASIA 31 0.0010
538 SPINAL OSTEOARTHRITIS 9 0.0010
539 IMMUNOSUPPRESSION 9 0.0010
540 ORGANISING PNEUMONIA 5 0.0010
541 BLOOD ALBUMIN DECREASED 8 0.0010
542 PULMONARY HYPERTENSION 21 0.0010
543 PLATELET COUNT INCREASED 13 0.0010
544 ADRENAL INSUFFICIENCY 12 0.0010
545 NEPHROPATHY TOXIC 11 0.0010
546 PHLEBITIS 5 0.0010
547 CACHEXIA 5 0.0010
548 MITRAL VALVE INCOMPETENCE 11 0.0010
549 SKIN NECROSIS 5 0.0010
550 C-REACTIVE PROTEIN INCREASED 35 0.0010
551 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
552 MYOCARDITIS 11 0.0010
553 ORAL DISORDER 7 0.0010
554 MOUTH HAEMORRHAGE 7 0.0010
555 HALLUCINATIONS, MIXED 4 0.0010
556 SERUM FERRITIN INCREASED 5 0.0009
557 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
558 NYSTAGMUS 5 0.0009
559 ASPARTATE AMINOTRANSFERASE INCREASED 50 0.0009
560 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
561 AORTIC VALVE INCOMPETENCE 4 0.0009
562 PULMONARY MASS 14 0.0009
563 HERPES ZOSTER 54 0.0009
564 LUNG NEOPLASM 4 0.0009
565 CHOLECYSTITIS 11 0.0009
566 RESPIRATORY TRACT INFECTION 24 0.0009
567 HYPERTHERMIA 7 0.0009
568 DIVERTICULUM INTESTINAL 4 0.0009
569 JAW DISORDER 5 0.0009
570 ORAL CANDIDIASIS 12 0.0009
571 TREATMENT FAILURE 75 0.0009
572 LYMPHOCYTE COUNT DECREASED 16 0.0009
573 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 21 0.0009
574 RENAL FAILURE ACUTE 38 0.0009
575 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
576 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
577 TOOTH ABSCESS 9 0.0009
578 ECCHYMOSIS 6 0.0009
579 NEUROLOGICAL SYMPTOM 5 0.0009
580 BLOOD DISORDER 7 0.0009
581 ISCHAEMIA 4 0.0009
582 UROSEPSIS 8 0.0009
583 VASCULITIS 10 0.0009
584 JAUNDICE 23 0.0009
585 ANOREXIA 11 0.0009
586 METASTASES TO CENTRAL NERVOUS SYSTEM 11 0.0009
587 TACHYCARDIA 75 0.0008
588 CARDIAC TAMPONADE 4 0.0008
589 DISEASE RECURRENCE 40 0.0008
590 ODYNOPHAGIA 5 0.0008
591 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
592 ATELECTASIS 8 0.0008
593 PULMONARY OEDEMA 37 0.0008
594 CELLULITIS 41 0.0008
595 PYELONEPHRITIS 7 0.0008
596 INFLAMMATORY MARKER INCREASED 4 0.0008
597 COLON CANCER 12 0.0008
598 PRODUCT USE IN UNAPPROVED INDICATION 199 0.0008
599 AMENORRHOEA 14 0.0008
600 HYPOCALCAEMIA 15 0.0008
601 MENTAL STATUS CHANGES 22 0.0008
602 PNEUMONIA 254 0.0008
603 OSTEOMYELITIS 14 0.0008
604 ORAL HERPES 15 0.0008
605 HYPERGLYCAEMIA 28 0.0008
606 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
607 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
608 BLOOD LACTIC ACID INCREASED 4 0.0008
609 LIVER FUNCTION TEST ABNORMAL 22 0.0008
610 HAEMATOCRIT DECREASED 15 0.0008
611 FLUID OVERLOAD 11 0.0008
612 POLYNEUROPATHY 9 0.0008
613 HEPATIC STEATOSIS 14 0.0008
614 BREAST CANCER METASTATIC 8 0.0007
615 LIVER DISORDER 33 0.0007
616 ANAL ABSCESS 4 0.0007
617 GINGIVITIS 4 0.0007
618 SHOCK HAEMORRHAGIC 6 0.0007
619 PULMONARY FIBROSIS 14 0.0007
620 SINUS BRADYCARDIA 7 0.0007
621 LEUKOCYTOSIS 13 0.0007
622 INTRACRANIAL PRESSURE INCREASED 4 0.0007
623 LUNG DISORDER 35 0.0007
624 SKIN INFECTION 8 0.0007
625 STATUS EPILEPTICUS 8 0.0007
626 BLOOD PRESSURE ABNORMAL 14 0.0007
627 PANCREATITIS 37 0.0007
628 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
629 BLOOD URIC ACID INCREASED 4 0.0007
630 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
631 HYPOKINESIA 10 0.0007
632 HYPOVOLAEMIA 4 0.0007
633 RASH MACULO-PAPULAR 15 0.0007
634 ATAXIA 8 0.0007
635 HAEMOGLOBIN DECREASED 69 0.0007
636 HYPERLIPIDAEMIA 8 0.0007
637 OPTIC NEURITIS 6 0.0007
638 GINGIVAL BLEEDING 9 0.0007
639 HYPOTENSION 132 0.0007
640 MUSCLE SPASTICITY 8 0.0007
641 HYPERCALCAEMIA 8 0.0006
642 HAEMOLYSIS 5 0.0006
643 HAEMOPTYSIS 18 0.0006
644 CHOLANGITIS 4 0.0006
645 ILEUS 8 0.0006
646 SKIN REACTION 9 0.0006
647 ARTERIOSCLEROSIS 6 0.0006
648 TORSADE DE POINTES 5 0.0006
649 GASTROINTESTINAL HAEMORRHAGE 53 0.0006
650 INTERNATIONAL NORMALISED RATIO INCREASED 18 0.0006
651 GENERAL PHYSICAL HEALTH DETERIORATION 73 0.0006
652 BLOOD CALCIUM DECREASED 7 0.0006
653 CEREBRAL INFARCTION 15 0.0006
654 LUNG NEOPLASM MALIGNANT 25 0.0006
655 PULMONARY CONGESTION 8 0.0006
656 IMMUNODEFICIENCY 9 0.0006
657 ELECTROLYTE IMBALANCE 7 0.0006
658 CAESAREAN SECTION 7 0.0006
659 PAIN IN JAW 17 0.0006
660 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
661 BLOOD CREATININE INCREASED 39 0.0006
662 FULL BLOOD COUNT DECREASED 12 0.0006
663 EMPHYSEMA 6 0.0006
664 HYPOTHERMIA 6 0.0006
665 MOTOR DYSFUNCTION 6 0.0006
666 HEPATIC CIRRHOSIS 11 0.0006
667 DEEP VEIN THROMBOSIS 38 0.0006
668 OFF LABEL USE 506 0.0006
669 RENAL FAILURE 76 0.0006
670 SUDDEN DEATH 6 0.0006
671 HEPATOCELLULAR INJURY 8 0.0006
672 INFLAMMATION 29 0.0006
673 THERAPEUTIC RESPONSE DECREASED 34 0.0006
674 FACIAL PAIN 5 0.0006
675 CHILLS 65 0.0006
676 MULTIPLE SCLEROSIS RELAPSE 38 0.0006
677 HAEMATEMESIS 14 0.0006
678 HIDRADENITIS 5 0.0005
679 EXOSTOSIS 5 0.0005
680 GRAND MAL CONVULSION 5 0.0005
681 BLOOD GLUCOSE ABNORMAL 10 0.0005
682 HEPATIC ENCEPHALOPATHY 5 0.0005
683 PERICARDITIS 9 0.0005
684 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
685 DIARRHOEA HAEMORRHAGIC 5 0.0005
686 HYDRONEPHROSIS 4 0.0005
687 PERITONITIS 11 0.0005
688 LIPASE INCREASED 4 0.0005
689 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
690 PROCEDURAL COMPLICATION 4 0.0005
691 RENAL IMPAIRMENT 43 0.0005
692 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
693 COVID-19 PNEUMONIA 6 0.0005
694 HEPATITIS 13 0.0005
695 DISORIENTATION 20 0.0005
696 GINGIVAL PAIN 4 0.0005
697 COORDINATION ABNORMAL 7 0.0005
698 HAEMATOMA 13 0.0005
699 METABOLIC ACIDOSIS 16 0.0005
700 DRUG INTERACTION 79 0.0005
701 HAEMATURIA 17 0.0005
702 DIALYSIS 7 0.0005
703 SUBDURAL HAEMATOMA 7 0.0005
704 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
705 NERVOUS SYSTEM DISORDER 15 0.0005
706 EOSINOPHIL COUNT INCREASED 4 0.0005
707 TENDERNESS 5 0.0005
708 CARDIO-RESPIRATORY ARREST 20 0.0005
709 NEUROPATHY PERIPHERAL 45 0.0005
710 CARDIAC FAILURE CONGESTIVE 38 0.0005
711 FACIAL PARALYSIS 4 0.0005
712 DIPLOPIA 12 0.0005
713 OEDEMA 25 0.0005
714 BONE PAIN 27 0.0005
715 HAEMORRHAGE 48 0.0005
716 INTERSTITIAL LUNG DISEASE 22 0.0005
717 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
718 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
719 DELUSION 7 0.0005
720 MALIGNANT MELANOMA 6 0.0004
721 MALNUTRITION 5 0.0004
722 FISTULA 5 0.0004
723 ACUTE KIDNEY INJURY 68 0.0004
724 BODY TEMPERATURE INCREASED 9 0.0004
725 ACUTE MYOCARDIAL INFARCTION 13 0.0004
726 ULCER 7 0.0004
727 ACUTE HEPATIC FAILURE 6 0.0004
728 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
729 RESPIRATORY DISORDER 13 0.0004
730 OVARIAN CANCER 4 0.0004
731 HYPOMAGNESAEMIA 6 0.0004
732 MOUTH ULCERATION 9 0.0004
733 EPILEPSY 13 0.0004
734 PHOTOSENSITIVITY REACTION 7 0.0004
735 PARALYSIS 6 0.0004
736 MUSCLE RIGIDITY 5 0.0004
737 CHOLESTASIS 8 0.0004
738 TOXICITY TO VARIOUS AGENTS 70 0.0004
739 FACE OEDEMA 7 0.0004
740 CARDIAC ARREST 34 0.0004
741 CIRCULATORY COLLAPSE 7 0.0004
742 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
743 SMALL INTESTINAL OBSTRUCTION 5 0.0004
744 GENERALISED OEDEMA 5 0.0004
745 GASTROINTESTINAL DISORDER 36 0.0004
746 PULMONARY EMBOLISM 38 0.0004
747 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
748 BRAIN INJURY 4 0.0004
749 BRADYCARDIA 21 0.0004
750 ATRIAL FIBRILLATION 38 0.0004
751 URINARY RETENTION 13 0.0004
752 PRODUCT USE ISSUE 71 0.0004
753 SENSORY DISTURBANCE 6 0.0004
754 HYPONATRAEMIA 21 0.0004
755 DYSARTHRIA 14 0.0004
756 CHOLELITHIASIS 12 0.0004
757 ASPIRATION 4 0.0004
758 SEIZURE 42 0.0004
759 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
760 BLOOD PRESSURE DECREASED 24 0.0004
761 HAEMORRHOIDS 7 0.0004
762 ALOPECIA 69 0.0004
763 DRUG INEFFECTIVE 463 0.0004
764 IMPAIRED QUALITY OF LIFE 5 0.0003
765 INTESTINAL OBSTRUCTION 13 0.0003
766 LOCAL SWELLING 6 0.0003
767 DRUG ERUPTION 6 0.0003
768 ARRHYTHMIA 16 0.0003
769 DYSPHAGIA 32 0.0003
770 COMA 16 0.0003
771 PROSTATE CANCER 27 0.0003
772 INFUSION RELATED REACTION 22 0.0003
773 VISUAL ACUITY REDUCED 11 0.0003
774 VIRAL INFECTION 11 0.0003
775 CORONARY ARTERY DISEASE 10 0.0003
776 BURSITIS 4 0.0003
777 OSTEOPENIA 5 0.0003
778 COGNITIVE DISORDER 15 0.0003
779 ABDOMINAL DISTENSION 33 0.0003
780 CONFUSIONAL STATE 51 0.0003
781 RED BLOOD CELL COUNT DECREASED 9 0.0003
782 CONVULSION 18 0.0003
783 NEOPLASM MALIGNANT 21 0.0003
784 INCREASED APPETITE 6 0.0003
785 HYPERKALAEMIA 11 0.0003
786 HIATUS HERNIA 4 0.0003
787 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
788 VENTRICULAR TACHYCARDIA 5 0.0003
789 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
790 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
791 HEPATIC ENZYME INCREASED 20 0.0003
792 SINUSITIS 30 0.0003
793 SKIN LESION 8 0.0003
794 PERIPHERAL COLDNESS 4 0.0003
795 ORTHOSTATIC HYPOTENSION 5 0.0003
796 LIVER INJURY 7 0.0003
797 ABDOMINAL PAIN 66 0.0003
798 BLINDNESS UNILATERAL 4 0.0003
799 BREAST CANCER 26 0.0003
800 SKIN CANCER 6 0.0003
801 PARAESTHESIA ORAL 4 0.0003
802 ABDOMINAL PAIN LOWER 7 0.0003
803 SWELLING FACE 18 0.0003
804 TOOTHACHE 5 0.0003
805 PELVIC PAIN 5 0.0003
806 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
807 GASTROENTERITIS 4 0.0003
808 HYPOPHAGIA 7 0.0003
809 RESTLESSNESS 10 0.0003
810 MELAENA 6 0.0003
811 MULTIPLE SCLEROSIS 13 0.0003
812 HAEMATOCHEZIA 15 0.0003
813 URINARY INCONTINENCE 8 0.0003
814 TOOTH DISORDER 6 0.0003
815 CONJUNCTIVITIS 5 0.0003
816 PARAESTHESIA 42 0.0003
817 BLOOD POTASSIUM DECREASED 8 0.0003
818 PREMATURE BABY 8 0.0003
819 BLOOD SODIUM DECREASED 5 0.0003
820 OEDEMA PERIPHERAL 32 0.0003
821 VOMITING 121 0.0003
822 PALLOR 7 0.0003
823 HEART RATE DECREASED 9 0.0003
824 DEHYDRATION 34 0.0003
825 EPISTAXIS 19 0.0003
826 CYSTITIS 8 0.0003
827 PREMATURE DELIVERY 4 0.0003
828 PRESCRIBED UNDERDOSE 5 0.0003
829 LOCALISED INFECTION 6 0.0002
830 NEURALGIA 6 0.0002
831 CARDIAC DISORDER 23 0.0002
832 COVID-19 43 0.0002
833 IMPAIRED HEALING 8 0.0002
834 CONDITION AGGRAVATED 73 0.0002
835 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
836 PSYCHOTIC DISORDER 7 0.0002
837 HALLUCINATION, VISUAL 5 0.0002
838 URINARY TRACT INFECTION 40 0.0002
839 JOINT INJURY 5 0.0002
840 LIVER FUNCTION TEST INCREASED 5 0.0002
841 ANAPHYLACTIC SHOCK 6 0.0002
842 SKIN ULCER 6 0.0002
843 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
844 DELIRIUM 8 0.0002
845 LETHARGY 13 0.0002
846 STEVENS-JOHNSON SYNDROME 5 0.0002
847 MOBILITY DECREASED 16 0.0002
848 DYSPNOEA 126 0.0002
849 DIARRHOEA 143 0.0002
850 BLINDNESS 9 0.0002
851 DRUG INTOLERANCE 21 0.0002
852 DEATH 186 0.0002
853 RHABDOMYOLYSIS 9 0.0002
854 DYSPNOEA EXERTIONAL 8 0.0002
855 MUSCULAR WEAKNESS 24 0.0002
856 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
857 PROTEINURIA 4 0.0002
858 ASTHENIA 78 0.0002
859 HYPOAESTHESIA 31 0.0002
860 EAR PAIN 4 0.0002
861 MENORRHAGIA 4 0.0002
862 PNEUMONIA ASPIRATION 5 0.0002
863 ANAPHYLACTIC REACTION 11 0.0002
864 OXYGEN SATURATION DECREASED 11 0.0002
865 HYPERSENSITIVITY 36 0.0002
866 BACK PAIN 45 0.0002
867 VISUAL IMPAIRMENT 24 0.0002
868 ACCIDENTAL OVERDOSE 7 0.0002
869 COUGH 53 0.0002
870 OSTEOARTHRITIS 8 0.0002
871 THROMBOSIS 15 0.0002
872 NIGHT SWEATS 6 0.0002
873 LACTIC ACIDOSIS 6 0.0002
874 NAUSEA 143 0.0002
875 SYNCOPE 18 0.0002
876 ORAL PAIN 4 0.0002
877 CHEST PAIN 33 0.0002
878 AGITATION 13 0.0002
879 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
880 MALAISE 77 0.0002
881 SKIN DISCOLOURATION 8 0.0002
882 BALANCE DISORDER 15 0.0002
883 MUSCLE TWITCHING 4 0.0002
884 PANCREATIC CARCINOMA 5 0.0002
885 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
886 DECREASED APPETITE 40 0.0002
887 SWELLING 16 0.0002
888 FATIGUE 132 0.0002
889 PRODUCTIVE COUGH 8 0.0002
890 DIABETIC KETOACIDOSIS 4 0.0002
891 HEADACHE 104 0.0002
892 PRESYNCOPE 4 0.0002
893 LOSS OF CONSCIOUSNESS 21 0.0002
894 DYSURIA 6 0.0002
895 NECK PAIN 9 0.0002
896 HYPERTENSION 34 0.0002
897 EYE PAIN 9 0.0002
898 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
899 ERYTHEMA 32 0.0002
900 DEAFNESS 4 0.0002
901 BLADDER CANCER 9 0.0002
902 MUSCULOSKELETAL PAIN 8 0.0002
903 ANHEDONIA 4 0.0002
904 ABNORMAL BEHAVIOUR 6 0.0002
905 RASH 65 0.0001
906 BRONCHITIS 11 0.0001
907 DISTURBANCE IN ATTENTION 8 0.0001
908 HALLUCINATION 11 0.0001
909 PALPITATIONS 17 0.0001
910 ABNORMAL DREAMS 4 0.0001
911 DEMENTIA 4 0.0001
912 SKIN EXFOLIATION 12 0.0001
913 CONSTIPATION 31 0.0001
914 HYPOACUSIS 6 0.0001
915 VAGINAL HAEMORRHAGE 6 0.0001
916 DRUG EFFECT INCOMPLETE 5 0.0001
917 MYALGIA 23 0.0001
918 HEART RATE INCREASED 13 0.0001
919 CEREBROVASCULAR ACCIDENT 22 0.0001
920 DRUG-INDUCED LIVER INJURY 4 0.0001
921 RASH ERYTHEMATOUS 6 0.0001
922 DYSKINESIA 5 0.0001
923 AMNESIA 8 0.0001
924 OSTEOPOROSIS 5 0.0001
925 WEIGHT DECREASED 33 0.0001
926 FLUID RETENTION 6 0.0001
927 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
928 CATARACT 7 0.0001
929 INFLUENZA 13 0.0001
930 RECTAL HAEMORRHAGE 5 0.0001
931 ARTHRITIS 9 0.0001
932 DEPRESSION 26 0.0001
933 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
934 RASH PRURITIC 6 0.0001
935 PAIN 67 0.0001
936 CHEST DISCOMFORT 11 0.0001
937 RENAL DISORDER 5 0.0001
938 BLISTER 6 0.0001
939 ANXIETY 30 0.0001
940 MUSCULOSKELETAL STIFFNESS 9 0.0001
941 DYSPHONIA 6 0.0001
942 PLASMA CELL MYELOMA 4 0.0001
943 MYOCARDIAL INFARCTION 17 0.0001
944 FALL 32 0.0001
945 POLLAKIURIA 4 0.0001
946 ECZEMA 5 0.0001
947 SOMNOLENCE 19 0.0001
948 DIZZINESS 47 0.0001
949 DRUG EFFECT DECREASED 5 0.0001
950 DYSPEPSIA 9 0.0001
951 ARTHROPATHY 5 0.0001
952 GAIT DISTURBANCE 17 0.0001
953 INJURY 6 0.0001
954 NASAL CONGESTION 5 0.0001
955 INFLUENZA LIKE ILLNESS 7 0.0001
956 SLEEP DISORDER 6 0.0001
957 HYPOGLYCAEMIA 4 0.0001
958 VERTIGO 5 0.0001
959 DISCOMFORT 5 0.0001
960 DIABETES MELLITUS 6 0.0001
961 TREMOR 13 0.0001
962 RHINORRHOEA 5 0.0001
963 WEIGHT INCREASED 17 0.0001
964 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
965 EMOTIONAL DISTRESS 9 0.0001
966 ABDOMINAL PAIN UPPER 15 0.0001
967 VISION BLURRED 10 0.0001
968 CONTUSION 7 0.0001
969 HYPERHIDROSIS 9 0.0001
970 ARTHRALGIA 29 0.0001
971 OROPHARYNGEAL PAIN 6 0.0001
972 PAIN IN EXTREMITY 18 0.0001
973 MUSCLE SPASMS 11 0.0001
974 URTICARIA 10 0.0001
975 MEMORY IMPAIRMENT 8 0.0001
976 BURNING SENSATION 4 0.0001
977 BLOOD PRESSURE INCREASED 7 0.0000
978 DRUG WITHDRAWAL SYNDROME 4 0.0000
979 ASTHMA 5 0.0000
980 PRURITUS 17 0.0000
981 ABDOMINAL DISCOMFORT 7 0.0000
982 INSOMNIA 11 0.0000
983 FLUSHING 4 0.0000
984 DRUG DEPENDENCE 6 0.0000
985 BLOOD GLUCOSE INCREASED 7 0.0000
986 FEELING ABNORMAL 8 0.0000
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
988 NO ADVERSE EVENT 6 0.0000
989 NASOPHARYNGITIS 4 0.0000